ADA and juvenile idiopathic arthritis: Objectives: To describe demographic and clinical features in a single-center cohort of JIA patients treated with ADA, grouped according to frequency and dosage of drug administration (1W vs 2W; 20 vs 40 mg); to assess ADA levels versus AAA titer and, finally, to investigate possible correlation between LOR and AAA.